>>> US Gapping up

Gapping up
In reaction to strong earnings/guidance:

MFIN +35.1%, HH +31.7%, PRSS +19.2%, REXX +17.5%, BIOC +17.3%, EKSO +11.1%
AVAV +7.1%, YIN +7.1%, PLCE +6.8%, ZAGG +6.7%, SCMP +6.7%, CLNE +6.6%, HRB +6%
TLGT +3.8%, NCS +3.4%, REGI +2.8%, OPTT +2%, GTT +2%, AERI +1.8%,RIGL +1.5%
OA +1.4%, TISI +1%, CERS +0.8%, CBIO +0.7%

M&A news:

TSL +5.7% (still checking, potentially related to pending to "go private" soon)
RH +1.9% (UK Betaville blogger suggests Williams-Sonoma is 'stalking Restoration Hardware')

Select EU financial names showing strength:

Other news:

PRKR +50.2% (continued strength following favorable patent ruling)
XTLB +14.4% (continued strength)
SHIP +12.6% (enters into a definitive agreement with one of its senior lenders for the early termination of a credit facility, which is expected to result into a material gain and equity accretion; the gain to the Company is estimated to be approximately $11.4 million after completion)
EXTR +7.4% ( to acquire Avaya's networking business for approximately $100 million )
NTLA +5.1% (presents updated data showing increased levels of genome editing efficiency in vivo and durability results with its CRISPR/Cas9 technology)
CLRB +4.5% (enters into a licensing agreement with the Wisconsin Alumni Research Foundation for intellectual property rights covering the method of use for CLR 131), TLGT +3.8% (receives approval of the Co's abbreviated new drug application from the FDA of Clobetasol Propionate Gel)
KERX +3.3% (FDA has accepted for review the supplemental New Drug Application for Auryxia)
OPK +2.8% (receives notification from the EC designating its oligonucleotide-based AntagoNAT)
FCSC +1.9% (Fibrocell Science entered into securities purchase agreement with existing investors for sale of $8.0 mln Series A Convertible Preferred Stock and accompanying warrants )
DKS +0.9% (slightly rebounding following yesterday's 9% decline, also several analysts defending stock this morning)

Analyst comments: